×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MTVA – metavia inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MTVA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/16
04:01 pm
mtva
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
Low
Report
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
1/15
09:32 am
mtva
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
High
Report
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
1/6
01:30 pm
mtva
MetaVia (NASDAQ:MTVA) had its price target raised by analysts at HC Wainwright from $12.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
MetaVia (NASDAQ:MTVA) had its price target raised by analysts at HC Wainwright from $12.00 to $40.00. They now have a "buy" rating on the stock.
1/5
08:41 am
mtva
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile [Yaho
High
Report
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile [Yaho
1/5
08:30 am
mtva
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile
Medium
Report
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile
12/29
08:31 am
mtva
MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference
Low
Report
MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference
12/22
08:31 am
mtva
MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement
High
Report
MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement
12/2
09:06 am
mtva
MetaVia Inc. Announces 1-for-11 Reverse Stock Split [Yahoo! Finance]
Low
Report
MetaVia Inc. Announces 1-for-11 Reverse Stock Split [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/16
04:05 pm
mtva
Form 8-K MetaVia Inc. For: Jan 15
Low
Report
Form 8-K MetaVia Inc. For: Jan 15
1/6
06:01 am
mtva
Form FWP MetaVia Inc. Filed by: MetaVia Inc.
Medium
Report
Form FWP MetaVia Inc. Filed by: MetaVia Inc.
1/5
05:23 pm
mtva
Form 8-K MetaVia Inc. For: Jan 05
Low
Report
Form 8-K MetaVia Inc. For: Jan 05
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: